Keyphrases
Once-daily
100%
Rosaceae
100%
Metronidazole
100%
Pustules
100%
Cream Formulation
100%
Papules
100%
Topical Metronidazole
100%
Treatment Group
35%
No Significant Difference
14%
Moderate to Severe
7%
Parallel Trials
7%
Twice Daily
7%
Pharmacokinetic Profile
7%
Commercially Available
7%
US Cities
7%
Clinical Site
7%
Frequency of Use
7%
Two-agent
7%
Erythema
7%
Patient Compliance
7%
Optimal Concentration
7%
Number of Drugs
7%
Optimum Frequency
7%
Lesion Count
7%
Drug Adverse Events
7%
Facial Erythema
7%
Physician Assessment
7%
Global Severity
7%
Once-daily Regimen
7%
In(III)
7%
Facial Lesion
7%
Pharmacology, Toxicology and Pharmaceutical Science
Metronidazole
100%
Pustule
100%
Rosacea
100%
Papule
100%
Treatment Group
29%
Group Trial
5%
Adverse Event
5%
Face Erythema
5%
Erythema
5%
Pharmacokinetics
5%